Quantitative serology assays for determination of antibody responses to Ebola virus glycoprotein and matrix protein in nonhuman primates and humans

Antiviral Research

Volumn 126, Issue , 2016, Pages 55-61

  Vu, Hong ^a   Shulenin, Sergey ^a   Grolla, Allen ^b   Audet, Jonathan ^b   He, Shihua ^b   Kobinger, Gary ^b   Unfer, Robert C ^a   Warfield, Kelly L ^a   Aman, M Javad ^a   Holtsberg, Frederick W ^a  

^a Integrated BioTherapeutics Inc   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Antibodies; Ebola virus; Human; Nonhuman primate; Serology ELISA; Vaccine

Indexed keywords

MATRIX PROTEIN; VIRUS GLYCOPROTEIN; EBOLA VACCINE; GLYCOPROTEIN; VIRUS ANTIBODY; VP40 PROTEIN, VIRUS;

ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; EBOLAVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SEROLOGY; ANIMAL; ANTIBODY PRODUCTION; BLOOD; DISEASE MODEL; EBOLA HEMORRHAGIC FEVER; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; MACACA; MACACA FASCICULARIS; MALE; PROCEDURES; PROTEIN ENGINEERING; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DISEASE MODELS, ANIMAL; EBOLA VACCINES; EBOLAVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HEK293 CELLS; HEMORRHAGIC FEVER, EBOLA; HUMANS; MACACA; MACACA FASCICULARIS; MALE; PROTEIN ENGINEERING; REPRODUCIBILITY OF RESULTS; VIRAL MATRIX PROTEINS;

EID: 84952802091     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2015.11.012     Document Type: Article

References (17)

1. S. Bavari, C.M. Bosio, E. Wiegand, G. Ruthel, A.B. Will, T.W. Geisbert, M. Hevey, C. Schmaljohn, A. Schmaljohn, and M.J. Aman Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses J. Exp. Med. 195 2002 593 602
2. P. Becquart, T. Mahlakoiv, D. Nkoghe, and E.M. Leroy Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus PLoS One 9 2014 e96360
3. P. Becquart, N. Wauquier, T. Mahlakoiv, D. Nkoghe, C. Padilla, M. Souris, B. Ollomo, J.P. Gonzalez, X. De Lamballerie, M. Kazanji, and E.M. Leroy High prevalence of both humoral and cellular immunity to Zaire ebolavirus among rural populations in Gabon PLoS One 5 2010 e9126
4. H. Feldmann, and M.P. Kiley Classification, structure, and replication of filoviruses Curr. Top. Microbiol. Immunol. 235 1999 1 21
5. H. Feldmann, and H.D. Klenk Marburg and Ebola viruses Adv. Virus Res. 47 1996 1 52
6. S.K. Gire, A. Goba, K.G. Andersen, R.S. Sealfon, D.J. Park, L. Kanneh, S. Jalloh, M. Momoh, M. Fullah, G. Dudas, S. Wohl, L.M. Moses, N.L. Yozwiak, S. Winnicki, C.B. Matranga, C.M. Malboeuf, J. Qu, A.D. Gladden, S.F. Schaffner, X. Yang, P.P. Jiang, M. Nekoui, A. Colubri, M.R. Coomber, M. Fonnie, A. Moigboi, M. Gbakie, F.K. Kamara, V. Tucker, E. Konuwa, S. Saffa, J. Sellu, A.A. Jalloh, A. Kovoma, J. Koninga, I. Mustapha, K. Kargbo, M. Foday, M. Yillah, F. Kanneh, W. Robert, J.L. Massally, S.B. Chapman, J. Bochicchio, C. Murphy, C. Nusbaum, S. Young, B.W. Birren, D.S. Grant, J.S. Scheiffelin, E.S. Lander, C. Happi, S.M. Gevao, A. Gnirke, A. Rambaut, R.F. Garry, S.H. Khan, and P.C. Sabeti Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak Science 345 2014 1369 1372
7. G. Kallstrom, K.L. Warfield, D.L. Swenson, S. Mort, R.G. Panchal, G. Ruthel, S. Bavari, and M.J. Aman Analysis of Ebola virus and VLP release using an immunocapture assay J. Virol. Methods 127 2005 1 9
8. J.H. Kuhn, S.R. Radoshitzky, A.C. Guth, K.L. Warfield, W. Li, M.J. Vincent, J.S. Towner, S.T. Nichol, S. Bavari, H. Choe, M.J. Aman, and M. Farzan Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor J. Biol. Chem. 281 2006 15951 15958
9. J.E. Lee, M.L. Fusco, A.J. Hessell, W.B. Oswald, D.R. Burton, and E.O. Saphire Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor Nature 454 2008 177 182
10. K. Miura, A.C. Orcutt, O.V. Muratova, L.H. Miller, A. Saul, and C.A. Long Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines Vaccine 26 2008 193 200
11. C.D. Murin, M.L. Fusco, Z.A. Bornholdt, X. Qiu, G.G. Olinger, L. Zeitlin, G.P. Kobinger, A.B. Ward, and E.O. Saphire Structures of protective antibodies reveal sites of vulnerability on Ebola virus Proc. Natl. Acad. Sci. U. S. A. 111 2014 17182 17187
12. T. Noda, H. Sagara, E. Suzuki, A. Takada, H. Kida, and Y. Kawaoka Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP J. Virol. 76 2002 4855 4865
13. N.J. Sullivan, J.E. Martin, B.S. Graham, and G.J. Nabel Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule Nat. Rev. Microbiol. 7 2009 393 400
14. D.L. Swenson, K.L. Warfield, K. Kuehl, T. Larsen, M.C. Hevey, A. Schmaljohn, S. Bavari, and M.J. Aman Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein(1) FEMS Immunol. Med. Microbiol. 40 2004 27 31
15. A. Voller, A. Bartlett, and D.E. Bidwell Enzyme immunoassays with special reference to ELISA techniques J. Clin. Pathol. 31 1978 507 520
16. K.L. Warfield, C.M. Bosio, B.C. Welcher, E.M. Deal, M. Mohamadzadeh, A. Schmaljohn, M.J. Aman, and S. Bavari Ebola virus-like particles protect from lethal Ebola virus infection Proc. Natl. Acad. Sci. U. S. A. 100 2003 15889 15894
17. K.L. Warfield, J.M. Dye, J.B. Wells, R.C. Unfer, F.W. Holtsberg, S. Shulenin, H. Vu, D.L. Swenson, S. Bavari, and M.J. Aman Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles PLoS One 10 2015 e0118881